Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleRPC4046, A Novel Anti-interleukin-13 Antibody, Blocks IL-13 Binding to IL-13 α1 and α2 Receptors: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation First-in-Human Study.AuthorsTripp, Catherine; Cuff, Carolyn; Campbell, Andrew; Hendrickson, Barbara; Voss, Jeff; Melim, Terry; Wu, Chengbin; Cherniack, Andrew; Kim, Kenneth; Tripp, Catherine S; Campbell, Andrew L; Hendrickson, Barbara A; Cherniack, Andrew DPublicationAdvances in Therapy, 2017, Vol 34, Issue 6, p1364ISSN0741-238XPublication typejournal articleDOI10.1007/s12325-017-0525-8